Welcome to kongre.net
Speaker
Director - Preclinical Development, Neumirna Therapeutics
Lluís Riera Ponsati, Director - Preclinical Development at Neumirna Therapeutics, is speaking at Novel CNS Biomarkers Summit Europe (London, United Kingdom, 30 Nov – 2 Dec 2026) in the session “Fireside Chat: New Efforts & Technologies to Avoid Invasive Lumbar Puncture – Comparing Blood-Based Biomarkers, Imaging Biomarkers, Olfactory Neurons, Extracellular Vesicles & Emerging Minimally Invasive Approaches”.
President & Chief Executive Officer, Progenra Inc
Vice President - Translational Biology, NRG Therapeutics
Neurological Disorders & Biofluid Specialist, Lundbeck
Founder & Chief Executive Officer, AltPep
Co-Founder & Chief Scientific Officer, Monument Therapeutics
Senior Scientist, Biosample Project Leader, Roche
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Lluís Riera Ponsati, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].